Activated platelet membrane

The activated platelet membrane refers to the dynamic surface of a platelet that has transitioned from a resting state to a pro-adhesive and pro-coagulant state, typically in response to vascular injury or inflammatory signals (StatPearls, 2023). This transformation involves the rapid translocation of P-selectin (CD62P) from internal alpha-granules to the cell surface and the conformational activation of the integrin alpha-IIb/beta-3 (GPIIb/IIIa) receptor, which facilitates fibrinogen binding and platelet aggregation (NCBI, 2022). The membrane also undergoes a flip-flop of phospholipids, exposing negatively charged phosphatidylserine that serves as a critical scaffold for the assembly of tenase and prothrombinase complexes in the coagulation cascade (Journal of Thrombosis and Haemostasis, 2019). In modern pharmacology, the activated platelet membrane is increasingly utilized as a target for biomimetic drug delivery systems, where nanoparticles are coated with these membranes to exploit their natural affinity for thrombi, atherosclerotic plaques, and tumor microenvironments (Nature Nanotechnology, 2015). Targeting the activated platelet membrane allows for localized delivery of thrombolytics, anti-inflammatory agents, or chemotherapeutics, potentially reducing systemic side effects (PubMed, 2021). However, therapeutic interventions must carefully balance the prevention of pathological thrombosis with the maintenance of normal hemostasis to avoid bleeding complications (Nature Reviews Cardiology, 2020).

Other names

Activated platelet surfacePlatelet-derived membraneProcoagulant platelet surfacePlatelet membrane

Binding to surface-expressed adhesion molecules such as P-selectin and activated glycoprotein IIb/IIIa, and providing a procoagulant phospholipid surface for the assembly of clotting factor complexes.